AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29554111 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 60
Study 27912954 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary and lifestyle recommendations based on Iranian traditional medicine (ITM) for 3 months
Number of subjects: 57
Study 27912954 — intervention group
Group type: COMPARATOR
Intervention: Routine dietary and lifestyle recommendations for 3 months
Number of subjects: 57
Study 23932541 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 80
Study 23932541 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotatory surgery
Number of subjects: 80
Study 22733639 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral-based intervention
Number of subjects: 488
Study 22733639 — intervention group
Group type: COMPARATOR
Intervention: Information-based intervention
Number of subjects: 488
Study 19893307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (tPA)
Number of subjects: 0
Study 19893307 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 17621470 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Imputation (MI) methods using SAS, R, and STATA for semi-continuous data
Number of subjects: 1060
Study 17621470 — intervention group
Group type: COMPARATOR
Intervention: Multiple Imputation (MI) methods
Number of subjects: 1060
Study 16253773 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine (200 mg/m2 i.v.) administered 15-30 min before each fraction of radiation
Number of subjects: 303
Study 16253773 — intervention group
Group type: COMPARATOR
Intervention: RT alone (control)
Number of subjects: 303
Study 10680028 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg/day
Number of subjects: 1105
Study 10680028 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 40 mg/day
Number of subjects: 1105
Study 9253390 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction models based on data from the first and second visit
Number of subjects: 5
Study 9253390 — intervention group
Group type: COMPARATOR
Intervention: Initial costs per randomization
Number of subjects: 5
Study 28443835 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% boric acid solution
Number of subjects: 115
Study 28443835 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA + NaOCl
Number of subjects: 115
Study 28443835 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine
Number of subjects: 115
Study 28443835 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCl for 5 min and 17% EDTA for 3 min
Number of subjects: 115
Study 28443835 — intervention group
Group type: COMPARATOR
Intervention: Control, no irrigant
Number of subjects: 115
Study 28443835 — intervention group
Group type: COMPARATOR
Intervention: 5% boric acid solution at 55°C for 60s
Number of subjects: 115
Study 2427859 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg
Number of subjects: 0
Study 2427859 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 400 mg
Number of subjects: 0
Study 2427859 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 600 mg
Number of subjects: 0
Study 2427859 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol (all doses)
Number of subjects: 0
Study 30146932 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (1-g capsules daily)
Number of subjects: 15480
Study 30146932 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 15480
Study 26886419 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid-artery stenting with embolic protection
Number of subjects: 1453
Study 26886419 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 1453
Study 24107760 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine controlled release
Number of subjects: 74
Study 24107760 — intervention group
Group type: COMPARATOR
Intervention: Bupropion extended release
Number of subjects: 74
Study 21148666 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant ablation surgery (AS)
Number of subjects: 132
Study 21148666 — intervention group
Group type: COMPARATOR
Intervention: Regular cardiac surgery
Number of subjects: 132
Study 18714251 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine electrostimulation
Number of subjects: 10
Study 18714251 — intervention group
Group type: EXPERIMENTAL
Intervention: Water exercises
Number of subjects: 10
Study 18714251 — intervention group
Group type: COMPARATOR
Intervention: Dry exercises
Number of subjects: 10
Study 18714251 — intervention group
Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 10
Study 17162995 — intervention group
Group type: EXPERIMENTAL
Intervention: 200‐mg modafinil
Number of subjects: 8
Study 17162995 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 8
Study 14566116 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory laparotomy (AEL)
Number of subjects: 102
Study 14566116 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy (ADL)
Number of subjects: 102
Study 14566116 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy (BDL)
Number of subjects: 102
Study 14566116 — intervention group
Group type: COMPARATOR
Intervention: Expectant nonoperative management (BNOM)
Number of subjects: 102
Study 10902983 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed milk + micronutrients (E)
Number of subjects: 136
Study 10902983 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk + micronutrients (M)
Number of subjects: 136
Study 10902983 — intervention group
Group type: COMPARATOR
Intervention: Skimmed milk (S)
Number of subjects: 136
Study 9113587 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominantly total circulatory arrest
Number of subjects: 171
Study 9113587 — intervention group
Group type: COMPARATOR
Intervention: Predominantly continuous low-flow cardiopulmonary bypass
Number of subjects: 171
Study 1609997 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% N2O in oxygen (O2)
Number of subjects: 300
Study 1609997 — intervention group
Group type: COMPARATOR
Intervention: O2 (no‐N2O group)
Number of subjects: 300
Study 1609997 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniectomy group
Number of subjects: 300
Study 1609997 — intervention group
Group type: COMPARATOR
Intervention: Cervical spine surgery (CSS) group
Number of subjects: 300
Study 3723795 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion of 700 ml at a rate of 5 ml/min
Number of subjects: 20
Study 3723795 — intervention group
Group type: COMPARATOR
Intervention: Furosemide 40 mg administered immediately before transfusion
Number of subjects: 20
Study 30171489 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured evidence-based physiotherapy with workplace dialogue
Number of subjects: 352
Study 30171489 — intervention group
Group type: COMPARATOR
Intervention: Structured evidence-based physiotherapy (reference care)
Number of subjects: 352
Study 27591231 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D ultrasound-guided embryo transfer
Number of subjects: 481
Study 27591231 — intervention group
Group type: COMPARATOR
Intervention: 2D ultrasound-guided embryo transfer
Number of subjects: 481
Study 24608198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent oxaliplatin (IO) administration (eight‐cycle blocks of oxaliplatin treatment)
Number of subjects: 140
Study 24608198 — intervention group
Group type: COMPARATOR
Intervention: Calcium and magnesium salts (Ca/Mg)
Number of subjects: 140
Study 24608198 — intervention group
Group type: COMPARATOR
Intervention: Continuous oxaliplatin (CO) administration
Number of subjects: 140
Study 22878491 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-propofol (KP)
Number of subjects: 60
Study 22878491 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-dexmedetomidine (KD)
Number of subjects: 60
Study 19477537 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (Filgrastim) at a dose of 10 μg/kg body weight/day subcutaneously
Number of subjects: 44
Study 19477537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 19477537 — intervention group
Group type: COMPARATOR
Intervention: G-CSF and Placebo
Number of subjects: 44
Study 18675521 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 22
Study 18675521 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase
Number of subjects: 22
Study 18675521 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone levels
Number of subjects: 22
Study 20049465 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue Doppler Imaging (TDI) assessment of systolic (S') and early diastolic (E') velocities of the septal and lateral mitral annulus.
Number of subjects: 60
Study 15735188 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min intense exercise (65% peak oxygen uptake)
Number of subjects: 13
Study 15735188 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 13
Study 12092938 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day comprehensive human sexuality seminar
Number of subjects: 422
Study 12092938 — intervention group
Group type: COMPARATOR
Intervention: 3 hours of HIV prevention videos (Control)
Number of subjects: 422
Study 9591867 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine
Number of subjects: 14
Study 9591867 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine
Number of subjects: 14
Study 9591867 — intervention group
Group type: EXPERIMENTAL
Intervention: astemizole
Number of subjects: 14
Study 9591867 — intervention group
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Number of subjects: 14
Study 7888688 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG) cut-off point of 6.4 mM
Number of subjects: 0
Study 3300241 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg/day)
Number of subjects: 18
Study 3300241 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50 mg/day)
Number of subjects: 18
Study 30501727 — intervention group
Group type: EXPERIMENTAL
Intervention: Blunt separation method
Number of subjects: 120
Study 30501727 — intervention group
Group type: COMPARATOR
Intervention: Routine longitudinal method
Number of subjects: 120
Study 27197908 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined home health education plus trained general practitioner intervention
Number of subjects: 1271
Study 27197908 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1271
Study 23278517 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (balls, Subgroup B.1 - retentive anchor with gold matrix)
Number of subjects: 69
Study 23278517 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (balls, Subgroup B.2 - retentive anchor with titanium matrix)
Number of subjects: 69
Study 23278517 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M (magnets)
Number of subjects: 69
Study 23278517 — intervention group
Group type: EXPERIMENTAL
Intervention: Group L (locator)
Number of subjects: 69
Study 22348650 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (ICBT) for 10 weeks
Number of subjects: 101
Study 22348650 — intervention group
Group type: COMPARATOR
Intervention: Attention control condition (online supportive therapy)
Number of subjects: 101
Study 21087474 — intervention group
Group type: EXPERIMENTAL
Intervention: Support groups recommended by trained general practitioners (Arm B)
Number of subjects: 390
Study 21087474 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver counseling recommended by trained general practitioners (Arm C)
Number of subjects: 390
Study 21087474 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Arm A)
Number of subjects: 390
Study 18516353 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium lactate supplementation (170 mg of calcium lactate and 60 mg of vitamin C, one tablet three times a day for four weeks)
Number of subjects: 43
Study 18516353 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium lactate supplementation
Number of subjects: 43
Study 16029296 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative physiotherapy
Number of subjects: 60
Study 16029296 — intervention group
Group type: COMPARATOR
Intervention: No physiotherapy (Control)
Number of subjects: 60
Study 14616171 — intervention group
Group type: EXPERIMENTAL
Intervention: MKC-733 (4 mg)
Number of subjects: 12
Study 10539777 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant mixture (440 alpha‐TE, 2000 RE of beta‐carotene, 500 mg ascorbic acid, 100 microg selenium, 30 mg zinc daily)
Number of subjects: 75
Study 10539777 — intervention group
Group type: COMPARATOR
Intervention: Single antioxidant supplements (Vitamin E, Vitamin A, Vitamin C)
Number of subjects: 75
Study 8644907 — intervention group
Group type: EXPERIMENTAL
Intervention: Special vessels and chlorine (5% calcium hypochlorite solution)
Number of subjects: 42
Study 8644907 — intervention group
Group type: EXPERIMENTAL
Intervention: Special vessels only
Number of subjects: 42
Study 8644907 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study 1751573 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic teaching group
Number of subjects: 43
Study 1751573 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsystematic teaching group
Number of subjects: 43
Study 1751573 — intervention group
Group type: COMPARATOR
Intervention: Control measurement (1 week before treatment)
Number of subjects: 43
Study 6805119 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete parenteral nutrition for 2 days preoperatively and 6 days postoperatively
Number of subjects: 20
Study 6805119 — intervention group
Group type: COMPARATOR
Intervention: Control group (no parenteral nutrition)
Number of subjects: 20
Study 6805119 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete parenteral nutrition
Number of subjects: 20
Study 28949260 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg CoQ10 per day for 12 weeks
Number of subjects: 40
Study 28949260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 26446784 — intervention group
Group type: EXPERIMENTAL
Intervention: Valcronic programme
Number of subjects: 74
Study 25490549 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF
Number of subjects: 24227
Study 25490549 — intervention group
Group type: COMPARATOR
Intervention: Smear microscopy
Number of subjects: 24227
Study 23098427 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco promotion activities (advertising, receipt of a free sample)
Number of subjects: 172
Study 23098427 — intervention group
Group type: EXPERIMENTAL
Intervention: School location and low socioeconomic status
Number of subjects: 172
Study 19895357 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweeping of membranes
Number of subjects: 351
Study 19895357 — intervention group
Group type: COMPARATOR
Intervention: No sweeping (control)
Number of subjects: 351
Study 17666123 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium checklist
Number of subjects: 49
Study 17666123 — intervention group
Group type: COMPARATOR
Intervention: Parent-assisted 24-h dietary recall
Number of subjects: 49
Study 15895197 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rheumatoid arthritis (diagnosed for less than 1 year)
Number of subjects: 133
Study 15895197 — intervention group
Group type: COMPARATOR
Intervention: Late rheumatoid arthritis (mean disease duration of 12.5 years)
Number of subjects: 133
Study 15895197 — intervention group
Group type: EXPERIMENTAL
Intervention: Both early and late rheumatoid arthritis
Number of subjects: 133
Study 15895197 — intervention group
Group type: COMPARATOR
Intervention: Long-standing rheumatoid arthritis
Number of subjects: 133
Study 15116352 — intervention group
Group type: EXPERIMENTAL
Intervention: CART and MARS models
Number of subjects: 2409
Study 10690983 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate (VPA) for 1 or 6 months
Number of subjects: 279
Study 10690983 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin for 1 week
Number of subjects: 279
Study 9088364 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional guidance for observers in small social groups
Number of subjects: 149
Study 9088364 — intervention group
Group type: COMPARATOR
Intervention: No instructional guidance for observers in small social groups
Number of subjects: 149
Study 9088364 — intervention group
Group type: COMPARATOR
Intervention: Hosts observing large numbers in social groups
Number of subjects: 149
Study 9088364 — intervention group
Group type: COMPARATOR
Intervention: Servers observing patrons in public establishments
Number of subjects: 149
Study 8249842 — intervention group
Group type: EXPERIMENTAL
Intervention: piretanide 6 mg + ramipril 5 mg
Number of subjects: 480
Study 8249842 — intervention group
Group type: COMPARATOR
Intervention: piretanide 3 mg
Number of subjects: 480
Study 8249842 — intervention group
Group type: COMPARATOR
Intervention: piretanide 6 mg
Number of subjects: 480
Study 8249842 — intervention group
Group type: COMPARATOR
Intervention: ramipril 2.5 mg
Number of subjects: 480
Study 8249842 — intervention group
Group type: COMPARATOR
Intervention: ramipril 5 mg
Number of subjects: 480
Study 8249842 — intervention group
Group type: COMPARATOR
Intervention: ramipril 10 mg
Number of subjects: 480
Study 8249842 — intervention group
Group type: EXPERIMENTAL
Intervention: piretanide + ramipril
Number of subjects: 480
Study 8249842 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 480
Study 2938471 — intervention group
Group type: COMPARATOR
Intervention: Flurbiprofen 150 mg per day for 6 days
Number of subjects: 201
Study 2938471 — intervention group
Group type: COMPARATOR
Intervention: Flurbiprofen 200 mg per day for 3 weeks
Number of subjects: 201
Study 2938471 — intervention group
Group type: COMPARATOR
Intervention: Flurbiprofen 400 mg per day for 7 days
Number of subjects: 201
Study 31431086 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-CT/MR fusion imaging
Number of subjects: 268
Study 31431086 — intervention group
Group type: COMPARATOR
Intervention: Routine CEUS
Number of subjects: 268
Study 31431086 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-CT/MR fusion imaging (for lesions >3 cm or close to major vessels)
Number of subjects: 268
Study 31431086 — intervention group
Group type: COMPARATOR
Intervention: Routine CEUS (for lesions >3 cm or close to major vessels)
Number of subjects: 268
Study 28803421 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative coronary plaque measurements (plaque volume, plaque burden, remodeling index, diameter stenosis)
Number of subjects: 260
Study 28803421 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative assessment of low CT attenuation plaque volume
Number of subjects: 260
Study 28803421 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive remodeling
Number of subjects: 260
Study 28803421 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaque burden
Number of subjects: 260
Study 27367521 — intervention group
Group type: EXPERIMENTAL
Intervention: TB treatment
Number of subjects: 0
Study 25143165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg
Number of subjects: 60
Study 25143165 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study 22828914 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block
Number of subjects: 360
Study 22828914 — intervention group
Group type: COMPARATOR
Intervention: Control block
Number of subjects: 360
Study 22828914 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block with stellate ganglion block
Number of subjects: 360
Study 22828914 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block without stellate ganglion block
Number of subjects: 360
Study 20465799 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, tailored walking programme
Number of subjects: 146
Study 20465799 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 146
Study 18493882 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine (n=28)
Number of subjects: 60
Study 18493882 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin (n=32)
Number of subjects: 60
Study 18493882 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 60
Study 18493882 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 60
Study 15639633 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet (LED 3.4MJ/day)
Number of subjects: 80
Study 15639633 — intervention group
Group type: COMPARATOR
Intervention: Control diet (5MJ/day)
Number of subjects: 80
Study 12593522 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) suspension for nebulization 3,200 microg day(‐1) b.i.d.
Number of subjects: 40
Study 12593522 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) suspension for nebulization 1,600 microg day(‐1) b.i.d.
Number of subjects: 40
Study 12593522 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) 800 microg day(‐1) b.i.d. via metered-dose inhaler (MDI) plus spacer
Number of subjects: 40
Study 12593522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9445198 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (18 g of omega-3 polyunsaturated fatty acids, PUFA)
Number of subjects: 60
Study 9445198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 7632640 — intervention group
Group type: EXPERIMENTAL
Intervention: Estraderm TTS 100 micrograms twice weekly
Number of subjects: 0
Study 7632640 — intervention group
Group type: COMPARATOR
Intervention: Estraderm TTS 200 micrograms twice weekly
Number of subjects: 0
Study 2774147 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 190
Study 2774147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 319816 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 0.1 mg
Number of subjects: 40
Study 319816 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 0.2 mg
Number of subjects: 40
Study 319816 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 0.4 mg
Number of subjects: 40
Study 319816 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 0.05 mg
Number of subjects: 40
Study 30871958 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpal stabilizing taping (CST)
Number of subjects: 30